Table 1.

Questions Addressed in This Statement: Diagnosis, Treatment, and Follow-up of PE During the COVID-19 Pandemic

PERT	•What is the role of PERT during this pandemic?
Diagnosis and risk stratification	•How does one approach diagnosis and risk stratification for patients with concurrent COVID-19 infection and PE using a PERT?
Treatment considerations	•Hospital admission •Which patients should be admitted to the hospital for PE treatment vs managed at home? •Intervention •Which patients with PE should be considered for procedural intervention? •Should thrombolytic approaches be substituted or used more liberally when interventional procedures are unavailable because of concerns about COVID-19? •How should procedural interventions for PE be scheduled and conducted? •For patients with diagnosed or suspected COVID-19 and PE who are deemed appropriate for intervention or surgery, what precautions are suggested when transporting to the procedural suite? •What precautions need to be implemented in the procedural suite or operating room for patients with diagnosed or suspected COVID-19?
Transfer of care	•Which patients with concurrent PE and confirmed or suspected COVID-19 should be transferred to a different facility for advanced therapy?
Follow-up	•How and when should clinical follow-up be scheduled? •What testing should be performed during follow-up?

COVID-19 = coronavirus disease 2019; PE = pulmonary embolism; PERT = pulmonary embolism response team.